As of June 7, 2025, ANBC Inc (SYUP) reports a Gross Margin of -115.69%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of ANBC Inc's Gross Margin
Over recent years, ANBC Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2007-12-31 | -115.69% |
| 2006-12-31 | -32.05% |
| 2005-12-31 | -68.58% |
| 2004-12-31 | -23.86% |
| 2003-12-31 | 43.13% |
This gradual decrease highlights how ANBC Inc manages its operational efficiency and pricing power over time.
Comparing ANBC Inc's Gross Margin to Peers
To better understand ANBC Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| ANBC Inc (SYUP) | -115.69% |
| RespireRx Pharmaceuticals Inc (RSPI) | 7775.20% |
| Nouveau Life Pharmaceuticals Inc (NOUV) | 7775.20% |
| Sunset Island Group Inc (SIGO) | 7775.20% |
| NanoSphere Health Sciences Inc (NSHS.CN) | 7775.20% |
| Rise Life Science Corp (RLSC.CN) | 6291.29% |
Compared to its competitors, ANBC Inc's Gross Margin is among the lowest compared to peers, suggesting potential challenges in production costs or pricing strategy.